| 发明名称 |
TREATMENT OF RESISTANT LESIONS |
| 摘要 |
Connexin protein modulation methods and compositions are provided for the healing of resistant lesions, including lesions on subjects with multiple venous leg ulcers or multiple diabetic foot ulcers, and other responder subjects. Also provided are kits and articles of manufacture comprising a connexin protein modulating agent, for example, a connexin 43 modulating agent for use in the healing of resistant lesions. |
| 申请公布号 |
US2017056468(A1) |
申请公布日期 |
2017.03.02 |
| 申请号 |
US201615247853 |
申请日期 |
2016.08.25 |
| 申请人 |
CoDa Therapeutics, Inc. |
发明人 |
EISENBUD David;PHILLIPS Anthony;BANNAN Scott;MATSUOKA Grove;Bradford DUFT |
| 分类号 |
A61K38/17;A61K9/06;A61K47/10;C12N15/113 |
主分类号 |
A61K38/17 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a resistant lesion on a subject, the method comprising administering to the subject a composition comprising a therapeutically effective amount of a connexin protein modulating agent. |
| 地址 |
San Diego CA US |
